NCT04511988View on ClinicalTrials.gov

Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal

NAActive, not recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 17, 2021

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Ovarian Cancer

Interventions

OTHER

Diagnostic Test

blood sample (20 ml) and biopsy

Trial Locations (1)

54506

Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Institut de Cancérologie de Lorraine

OTHER